glp-1 receptor agonist medicines Discovery of GLP-1–Based Drugs for the Treatment of Obesity GLP-1 Drug Savings: A Complete
Description
Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake
doi: 10.1016/j.mce.2014.10.025
doi: 10.1007/s00394-023-03205-w
E.Mandarim-de-LacerdaC
doi: 10.2337/db08-1651
Although some studies suggest gastroparesis is more common in type 2 diabetes, the USA-funded National Institutes of Health Gastroparesis Clinical Research Consortium reported a comparable prevalence, especially in longstanding and poorly controlled diabetes
